Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Suzanne Hayman

Showing results (1-10 of 72) with videos related to

Pageof 8
Sort By:
British Journal of Haematology|August 4, 2007
Waldenström macroglobulinaemiaRafael Fonseca, Suzanne Hayman
Seminars in Oncology|April 30, 2003
Angiogenesis in Waldenstrom's macroglobulinemiaS Vincent Rajkumar, Suzanne Hayman, Philip R Greipp
Current Treatment Options in Oncology|May 5, 2005
Current status of stem cell transplantation for multiple myelomaMorie A Gertz, Martha Q Lacy, Angela Dispenzieri, et al.
Leukemia & Lymphoma|January 19, 2008
Troponin T level as an exclusion criterion for stem cell transplantation in light-chain amyloidosisMorie Gertz, Martha Lacy, Angela Dispenzieri, et al.
Blood Cancer Journal|September 8, 2018
Lenalidomide and dexamethasone in patients with relapsed multiple myeloma and impaired renal function: PrE1003, a PrECOG studyJoseph Mikhael, Judith Manola, Amylou C Dueck, et al.
Clinical Lymphoma, Myeloma & Leukemia|January 14, 2024
An Open-Label Phase I Study of Metformin and Nelfinavir in Combination With Bortezomib in Patients With Relapsed and Refractory Multiple MyelomaIbrahim Alodhaibi, Sikander Ailawadhi, Gabriel P Burbano, et al.
Clinical Lymphoma & Myeloma|April 28, 2006
Cyclophosphamide mobilization does not improve outcome in patients receiving stem cell transplantation for multiple myelomaDavid Dingli, Grzegorz S Nowakowski, Angela Dispenzieri, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 25, 2013
Low levels of interleukin-1 receptor antagonist (IL-1RA) predict engraftment syndrome after autologous stem cell transplantation in POEMS syndrome and other plasma cell neoplasmsAlla Keyzner, Anita D'Souza, Martha Lacy, et al.
Archives of Dermatology|October 19, 2005
Successful treatment of scleromyxedema with autologous peripheral blood stem cell transplantationMartha Q Lacy, William J Hogan, Morie A Gertz, et al.
Bone Marrow Transplantation|March 17, 2022
Impact of maintenance therapy post autologous stem cell transplantation for multiple myeloma in early and delayed transplantDhauna Karam, Morie Gertz, Martha Lacy, et al.
Pageof 8

Showing results (1-10 of 72) with videos related to

Sort By:
Pageof 8
British Journal of Haematology|August 4, 2007
Waldenström macroglobulinaemiaRafael Fonseca, Suzanne Hayman
Seminars in Oncology|April 30, 2003
Angiogenesis in Waldenstrom's macroglobulinemiaS Vincent Rajkumar, Suzanne Hayman, Philip R Greipp
Current Treatment Options in Oncology|May 5, 2005
Current status of stem cell transplantation for multiple myelomaMorie A Gertz, Martha Q Lacy, Angela Dispenzieri, et al.
Leukemia & Lymphoma|January 19, 2008
Troponin T level as an exclusion criterion for stem cell transplantation in light-chain amyloidosisMorie Gertz, Martha Lacy, Angela Dispenzieri, et al.
Blood Cancer Journal|September 8, 2018
Lenalidomide and dexamethasone in patients with relapsed multiple myeloma and impaired renal function: PrE1003, a PrECOG studyJoseph Mikhael, Judith Manola, Amylou C Dueck, et al.
Clinical Lymphoma, Myeloma & Leukemia|January 14, 2024
An Open-Label Phase I Study of Metformin and Nelfinavir in Combination With Bortezomib in Patients With Relapsed and Refractory Multiple MyelomaIbrahim Alodhaibi, Sikander Ailawadhi, Gabriel P Burbano, et al.
Clinical Lymphoma & Myeloma|April 28, 2006
Cyclophosphamide mobilization does not improve outcome in patients receiving stem cell transplantation for multiple myelomaDavid Dingli, Grzegorz S Nowakowski, Angela Dispenzieri, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 25, 2013
Low levels of interleukin-1 receptor antagonist (IL-1RA) predict engraftment syndrome after autologous stem cell transplantation in POEMS syndrome and other plasma cell neoplasmsAlla Keyzner, Anita D'Souza, Martha Lacy, et al.
Archives of Dermatology|October 19, 2005
Successful treatment of scleromyxedema with autologous peripheral blood stem cell transplantationMartha Q Lacy, William J Hogan, Morie A Gertz, et al.
Bone Marrow Transplantation|March 17, 2022
Impact of maintenance therapy post autologous stem cell transplantation for multiple myeloma in early and delayed transplantDhauna Karam, Morie Gertz, Martha Lacy, et al.
Pageof 8